PHAT Phathom Pharmaceuticals, Inc.
P/E
--
Forward P/E
6.1631045
Price/Sales
2.005122
Beta
0.502
Div Yield
0.0%
Market Cap
--
Company Analysis
Latest News
Phathom's VOQUEZNA Drug Exclusivity Under FDA Review Amid Generic Challenge Litigation
Phathom Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has opened a public docket to review the New Chemical Entity (NCE)...
Phathom Discloses Lawsuit Challenging FDA's Market Exclusivity Grant for VOQUEZNA
Phathom Pharmaceuticals announced that BDR Pharmaceuticals has filed a lawsuit against the U.S. Food and Drug Administration (FDA) challenging the market...